Goldman Sachs analyst Rajan Sharma maintained a Sell rating on Roche Holding AG today and set a price target of CHF248.00. The company’s shares closed last Friday at $360.15.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Sharma is a 3-star analyst with an average return of 2.0% and a 57.32% success rate. Sharma covers the Healthcare sector, focusing on stocks such as AstraZeneca, UCB SA, and GlaxoSmithKline.
Roche Holding AG has an analyst consensus of Hold, with a price target consensus of $352.01, representing a -2.26% downside. In a report released on September 29, J.P. Morgan also maintained a Sell rating on the stock with a CHF253.50 price target.
The company has a one-year high of $362.66 and a one-year low of $269.80. Currently, Roche Holding AG has an average volume of 9,484.
Read More on RHHVF:
Disclaimer & DisclosureReport an Issue
- Exicure appoints Josephine Cardarelli as president, CSO
- Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
- Trump Weekly: White House announces drug pricing deal with Pfizer
- FDA approves Genentech’s Tecentriq + Lurbinectedin in ES-SCLC
- FDA approves combo of Jazz’s lurbinectedin and Roche’s atezolizumab for ES-SCLC
/Microsoft%20sign%20at%20the%20headquarters%20by%20VDB%20Photos%20via%20Shutterstock.jpg)
